Possible mechanisms of the protective effect of pretreatment with anipamil in ischemic-reperfused isolated rat hearts
- PMID: 1554868
Possible mechanisms of the protective effect of pretreatment with anipamil in ischemic-reperfused isolated rat hearts
Abstract
Rats were given anipamil (5 mg/kg) or glucose, intraperitoneally twice daily for 5 days. During this period the mean arterial blood pressure and heart rate were measured daily. The heart was then isolated and perfused. Energy metabolism and intracellular pH were monitored by 31P nuclear magnetic resonance spectroscopy during 30 minutes of ischemia followed by 30 minutes of reperfusion, with a simultaneous isovolumetric measurement of left ventricular contraction. Myocardial norepinephrine and glycogen were assayed immediately after excision of the heart, after 15 minutes oxygenated perfusion, at the end of ischemia and at the end of reperfusion. Metabolic and functional recovery during reperfusion were significantly better in hearts pretreated with anipamil (p less than 0.0005 vs controls). However, protection was not preceded by an effect on mean arterial pressure or heart rate in vivo, or a negative inotropic effect during control perfusion of the isolated hearts. There was no energy sparing effect during ischemia; but intracellular pH during ischemia stabilized at a higher level (p less than 0.0005 vs controls). Myocardial norepinephrine and glycogen stores were not decreased by pretreatment with anipamil, and their release or degradation due to ischemia and reperfusion were also not different from controls. Commonly known mechanisms of myocardial protection by calcium antagonists fail to explain the protection by pretreatment with anipamil as observed in our experiments, and alternative mechanisms are to be considered.
Similar articles
-
Effect of pretreatment with anipamil on a submaximal calcium paradox in the isolated rat heart.Cardioscience. 1990 Sep;1(3):213-6. Cardioscience. 1990. PMID: 2102810
-
Protective effect of pretreatment with the calcium antagonist anipamil on the ischemic-reperfused rat myocardium: a phosphorus-31 nuclear magnetic resonance study.J Am Coll Cardiol. 1988 May;11(5):1087-93. doi: 10.1016/s0735-1097(98)90069-9. J Am Coll Cardiol. 1988. PMID: 3356827
-
Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart.J Mol Cell Cardiol. 1999 Nov;31(11):1961-73. doi: 10.1006/jmcc.1999.1027. J Mol Cell Cardiol. 1999. PMID: 10591023
-
Fundamental mechanisms of action of calcium antagonists in myocardial ischemia.Am J Cardiol. 1987 Jan 30;59(3):75B-83B. doi: 10.1016/0002-9149(87)90086-5. Am J Cardiol. 1987. PMID: 2433934 Review.
-
Myocardial stunning: a role for calcium antagonists during reperfusion?Cardiovasc Res. 1992 Jan;26(1):20-4. doi: 10.1093/cvr/26.1.20. Cardiovasc Res. 1992. PMID: 1516108 Review. No abstract available.
Cited by
-
Anipamil prevents ST depression in patients with stable angina pectoris.Cardiovasc Drugs Ther. 1993 Dec;7(6):915-21. doi: 10.1007/BF00877727. Cardiovasc Drugs Ther. 1993. PMID: 8011571 Clinical Trial.
-
How do calcium antagonists differ in clinical practice?Cardiovasc Drugs Ther. 1994 Aug;8 Suppl 3:565-75. doi: 10.1007/BF00877225. Cardiovasc Drugs Ther. 1994. PMID: 7841090 Review.